Join the club for FREE to access the whole archive and other member benefits.

Joe Betts-LaCroix

American scientist and entrepreneur known for his discoveries in biophysics and for creating the world's smallest personal computer

Beginning in earth sciences at Harvard, Betts-LaCroix contributed to the field of long-term regulation of oxygen on Earth over multi-100 Million-year timespans, quantifying the effect of the burial efficiency of organic carbon as a feedback mechanism.

At MIT, he designed and built an autonomous, robotic system that enables research into ocean circulation patterns and climate change, by operating untended for up to one year at sea on battery power and collecting hyper-pure water samples at predetermined intervals.

In work at Caltech, Betts-LaCroix moved into biophysics, publishing a paper in Science that has been cited by more than 700 subsequent scientific works. In this work, he, along with David Beratan and José Onuchic proved for the first time that electron-transfer rates in proteins are determined by the electron orbital interactions in the protein structure.

Visit website: https://en.wikipedia.org/wiki/Joe_Betts-LaCroix

 bettslacroix

 bettslacroix

See also: Company Retro Biosciences - Single therapy for multiple age-related diseases

Details last updated 20-Nov-2021

Joe Betts-LaCroix is also referenced in the following:

ARDD 2023 - 10th Aging Research & Drug Discovery Meeting

28-Aug-2023 to 01-Sep-2023

Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen

Global Healthspan Summit 2023

29-Nov-2023 to 30-Nov-2023

Longevity summit organised by Hevolution Foundation (Riyadh,Saudi Arabia)

Longevity Summit Dublin 2023

17-Aug-2023 to 20-Aug-2023
Club discount available - click here

Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers

Joe Betts-LaCroix News

Multiply Labs signs $85m deal with Retro Bio to automate anti-ageing therapies

Multiply Labs signs $85m deal with Retro Bio to automate anti-ageing therapies

Longevity Technology - 15-May-2024

Promises faster development and wider access of cell therapies for age-related diseases